Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zymergen Inc. (ZY) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zymergen Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1645842.
Total stock buying since 2021: $1,000,000.
Total stock sales since 2021: $856,697.
Total stock option exercises since 2021: $125,230.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2022 | 0 | $0 | 215,745 | $856,697 | 0 | $0 |
2021 | 100,000 | $1,000,000 | 0 | $0 | 59,000 | $125,230 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2022-10 | 0 | $0 | 3,786 | $10,597 | 0 | $0 |
2022-09 | 0 | $0 | 10,606 | $23,438 | 0 | $0 |
2022-08 | 0 | $0 | 11,495 | $37,084 | 0 | $0 |
2022-07 | 0 | $0 | 5,721 | $7,562 | 0 | $0 |
2022-06 | 0 | $0 | 5,751 | $9,649 | 0 | $0 |
2022-05 | 0 | $0 | 6,288 | $11,254 | 0 | $0 |
2022-04 | 0 | $0 | 32,639 | $94,424 | 0 | $0 |
2022-03 | 0 | $0 | 25,000 | $95,350 | 0 | $0 |
2022-02 | 0 | $0 | 37,294 | $177,424 | 0 | $0 |
2022-01 | 0 | $0 | 77,165 | $389,915 | 0 | $0 |
2021-12 | 0 | $0 | 0 | $0 | 50,000 | $85,000 |
2021-11 | 100,000 | $1,000,000 | 0 | $0 | 0 | $0 |
2021-10 | 0 | $0 | 0 | $0 | 9,000 | $40,230 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-10-03 | Singh Enakshi (Chief Financial Officer) | Sale | 3,786 | 2.80 | 10,597 |
2022-09-02 | Singh Enakshi (Chief Financial Officer) | Sale | 3,928 | 2.21 | 8,680 |
2022-09-02 | Serber Zachariah (Chief Science Officer) | Sale | 3,268 | 2.21 | 7,222 |
2022-09-02 | Kim Mina (Chief Legal Officer) | Sale | 3,410 | 2.21 | 7,536 |
2022-08-11 | Serber Zachariah (Chief Science Officer) | Sale | 5,435 | 3.91 | 21,250 |
2022-08-02 | Serber Zachariah (Chief Science Officer) | Sale | 2,966 | 2.61 | 7,750 |
2022-08-02 | Kim Mina (Chief Legal Officer) | Sale | 3,094 | 2.61 | 8,084 |
2022-07-05 | Serber Zachariah (Chief Science Officer) | Sale | 2,797 | 1.32 | 3,697 |
2022-07-05 | Kim Mina (Chief Legal Officer) | Sale | 2,924 | 1.32 | 3,865 |
2022-06-02 | Serber Zachariah (Chief Science Officer) | Sale | 2,812 | 1.68 | 4,718 |
2022-06-02 | Kim Mina (Chief Legal Officer) | Sale | 2,939 | 1.68 | 4,931 |
2022-05-02 | Serber Zachariah (Chief Science Officer) | Sale | 3,082 | 1.79 | 5,516 |
2022-05-02 | Kim Mina (Chief Legal Officer) | Sale | 3,206 | 1.79 | 5,738 |
2022-04-01 | Kimball Aaron (Chief Technology Officer) | Sale | 32,639 | 2.89 | 94,424 |
2022-03-01 | Kimball Aaron (Chief Technology Officer) | Sale | 25,000 | 3.81 | 95,350 |
2022-02-22 | Serber Zachariah (Chief Science Officer) | Sale | 1,424 | 3.91 | 5,567 |
2022-02-14 | Serber Zachariah (Chief Science Officer) | Sale | 5,435 | 4.00 | 21,729 |
2022-02-07 | Serber Zachariah (Chief Science Officer) | Sale | 5,435 | 4.33 | 23,528 |
2022-02-01 | Kimball Aaron (Chief Technology Officer) | Sale | 25,000 | 5.06 | 126,600 |
2022-01-31 | Serber Zachariah (Chief Science Officer) | Sale | 5,435 | 5.03 | 27,359 |
2022-01-24 | Serber Zachariah (Chief Science Officer) | Sale | 21,730 | 4.76 | 103,456 |
2022-01-18 | Kimball Aaron (Chief Technology Officer) | Sale | 50,000 | 5.18 | 259,100 |
2021-12-28 | Singh Enakshi (Chief Financial Officer) | Option Ex | 50,000 | 1.70 | 85,000 |
2021-11-17 | Flatley Jay T (Chairman and Acting CEO) | Buy | 100,000 | 10.00 | 1,000,000 |
2021-10-06 | Kimball Aaron (Chief Technology Officer) | Option Ex | 9,000 | 4.47 | 40,230 |
Insider trading activities including stock purchases, stock sales, and option exercises of ZY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zymergen Inc. (symbol ZY, CIK number 1645842) see the Securities and Exchange Commission (SEC) website.